Thymic carcinoma overview

Jump to navigation Jump to search

Thymic Carcinoma Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Thymic carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Echocardiograph and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Thymic carcinoma overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Google Images

American Roentgen Ray Society Images of Thymic carcinoma overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Thymic carcinoma overview

CDC on Thymic carcinoma overview

Thymic carcinoma overview in the news

Blogs on Thymic carcinoma overview

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Thymic carcinoma overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]

Overview

Thymic carcinoma, also known as type C thymoma is a rare condition (less than 0.13/100,000/year) but should be included in the differential diagnosis of anterior mediastinic masses. It is a tumor of the thymic epithelium, like thymoma, but it is associated with lack of immature lymphocytes and often presents with more invasive or metastatic disease.

Thymic carcinomas can metastasize, generally to pleura, kidney, bone, liver or brain

References